SIRT5 was shown to be overexpressed in advanced NSCLC and linked to poor prognosis in a study by Lu et al. that highlighted the possible function of SIRT5 in promoting lung cancer development and drug resistance [66]. Here, SIRT5 is linked to lung carcinoma.